Kuehn Law Encourages ITI, RXRX, GVP, and OBDE Investors to Contact Law Firm
12. August 2024 09:23 ET
|
KUEHN LAW, PLLC
Kuehn Law Encourages ITI, RXRX, GVP, and OBDE Investors to Contact Law Firm
Recursion updates L(earnings) call on August 8th to 8:30 am ET / 6:30 am MT
08. August 2024 01:32 ET
|
Recursion Pharmaceuticals
Salt Lake City, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, will provide business updates...
Recursion to Report Second Quarter 2024 Business Updates and Financial Results on August 8th
05. August 2024 16:01 ET
|
Recursion Pharmaceuticals
Salt Lake City, Aug. 05, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, announced today it will provide...